Clinical Trial Update: A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients [NA]

View source ↗

Summary

A single-site, open-label, non-controlled trial evaluated topical cidofovir 1% three nights per week for four weeks in HIV-infected individuals with high-grade …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Intraepithelial Neoplasia
• HIV Infection

Drugs mentioned

• Cidofovir (cidofovir)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV | NA | Status: COMPLETED